Advertisement
Morphic Holding Inc. (MORF)
NASDAQ: MORF
· Real-Time Price · USD
56.99
0.02 (0.04%)
At close: Aug 15, 2024, 8:00 PM
0.04% (1D)
| Bid | n/a |
| Market Cap | 2.86B |
| Revenue (ttm) | -60.24M |
| Net Income (ttm) | -179.83M |
| EPS (ttm) | -3.83 |
| PE Ratio (ttm) | -14.879895561357703 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 1,739,150 |
| Avg. Volume (20D) | 2,453,038 |
| Open | 56.97 |
| Previous Close | 56.97 |
| Day's Range | 56.97 - 57.00 |
| 52-Week Range | 19.34 - 57.00 |
| Beta | 1.49 |
About MORF
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmon...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 27, 2019
Employees 128
Stock Exchange NASDAQ
Ticker Symbol MORF
Website https://www.morphictx.com
Advertisement
Analyst Forecast
According to 4 analyst ratings, the average rating for MORF stock is "Hold." The 12-month stock price forecast is $57, which is an increase of 0.02% from the latest price.
Stock Forecasts9 months ago
Morphic shares are trading higher after Eli Lilly ...
Unlock content with
Pro Subscription